Caregen Co., Ltd. announces an Equity Buyback for 250,000 shares.
December 06, 2016
Share
Caregen Co., Ltd. (KOSDAQ:A214370) announces a share repurchase program. Under the program, the company will repurchase up to 250,000 shares for a total of KRW 16,925 million, which is based on the closing price of KRW 67,700 per share on December 6, 2016. The company will repurchase its shares on the open market. The purpose of the share repurchase program is to stabilize the share price and to enhance shareholder value. The maximum number of shares that the company may repurchase on any day is 30,993 shares. The actual amount for the repurchase may change according to the changes in the stock price. The share repurchase program is valid until March 7, 2017. As of December 6, 2016, the company had 257,730 shares in treasury within scope available for dividend and had no shares in treasury through other repurchase.
Caregen Co., LTD is a Korea-based company mainly engaged in the manufacture of cosmeceuticals and dermal fillers. The Company manufactures HSR CEs which used for improving facial wrinkles and strengthening protect wet under the brand name of Dermaheal, aquashines which used for keeping the shin whitening and promoting skin cells activation under the brand name of REVOFIL, HL CEs which used for treating hair loss, hair filler excell C'rums which used for promoting hair growth and preventing hair lose, LL CEs which used for promoting fat decomposition and prevent fat accumulation, hydra B5 Gels, ultra AW500s, eye filler masks, efficacy raw materials including growth facors and biomimetic peptides, and others. The Company distributes its products within domestic market and to overseas markets.
CAREGEN CO., LTD. 
